Martin Roper
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
Highest-materiality recent filing
MGP shareholders elect directors, ratify KPMG, approve say-on-pay and 2024 equity plan
All four Group A director nominees elected: Julie M. Francis (~17.8M for), Thomas A. Gerke (~15.4M for), Donn Lux (~16.9M for), Todd B. Siwak (~14.7M for).
MGP Ingredients Q1 net loss $134.8M on $179.5M non-cash impairments; adj. EPS $0.15
Revenue fell 13% to $106.4M; net loss of $134.8M ($6.30 basic loss) vs year-ago loss of $3.0M.
Temporary idling of Limestone Branch (Lebanon, KY) and Lux Row (Bardstown, KY) effective May 1, 2026.
MGP Ingredients Q4 net loss $134.6M includes $152.6M impairment; FY sales -24%
Q4 net loss of $134.6M, includes $152.6M non-cash goodwill/intangibles impairment (Branded Spirits).
MGP Ingredients terminates CHRO and CCO as part of leadership reorganization
Board approved reorganization; CHRO Erika Lapish and CCO Amel Pasagic depart effective Feb 20, 2026.
Karen Seaberg retired from MGP Board effective December 14, 2025 after over 15 years of service, including as Chairman from 2014 to 2024.
MGP Ingredients Q3 sales -19% to $130.9M, net income -35%; raises FY adjusted EBITDA, EPS outlook
Q3 consolidated sales $130.9M (-19% YoY); gross profit $49.4M (-25%); net income $15.4M (-35%).
MGP Ingredients Q2 sales -24% to $145.5M, net income -55%; new CEO Julie Francis appointed
Sales down 24% to $145.5M; gross profit -30% to $58.4M; margin 40.1% (-350bps).
MGP Ingredients appoints Julie Francis as CEO; reaffirms FY2025 guidance
Julie Francis named President and CEO effective July 21, 2025; previously COO at Schwan's Company.
MGP Ingredients elects Martin Roper as Chairman; appoints new committee chairs
Martin Roper elected Chairman of the Board effective May 22, 2025; has 25+ years beverage industry experience including CEO of Boston Beer and Vita Coco.
MGP Ingredients Q1 net loss $3.1M; sales down 29%, reaffirms 2025 outlook
Net loss of $3.1M vs $19.9M income in Q1 2024; basic EPS loss $0.14.
MGP Ingredients upsizes revolver to $500M, extends maturity to 2030
Revolving credit facility increased from $400M to $500M.
MGP Ingredients elects Gerardo Lopez and Martin Roper to board; Preet Michelson resigns
Gerardo I. Lopez (former CEO of AMC Entertainment) and Martin Roper (CEO of Vita Coco, former CEO of Boston Beer) elected as Group B directors effective April 14, 2025.
MGP Ingredients adopts new LTI program with PSUs and updated RSU awards
Committee approved new LTI design: annual grants of PSUs with forward-looking performance goals and time-vested RSUs, effective 2025.
Three MGP Ingredients directors plan to sell shares under 10b5-1 plans
Donn Lux, Karen Seaberg, and Lori Mingus expected to sell MGPI common stock.
MGP Ingredients Q4 net loss $42M on goodwill impairment; 2025 guidance well below 2024
Q4 net loss $42M ($1.91 basic EPS loss) includes $73.8M non-cash goodwill impairment; adjusted EPS $1.57.
MGP Ingredients approves amended Short Term Incentive Plan effective Jan 1, 2025
Amended STIP effective Jan 1, 2025; cash bonus pool set at at least 80% of collective target bonuses.
MGP Ingredients names CFO Brandon Gall interim CEO; Donn Lux becomes chairman
David Bratcher steps down as CEO and resigns from board effective Dec 31, 2024; gets transition and severance benefits.
Consolidated sales $161.5M, down 24% YoY; excluding Atchison distillery, down 14%.
MGP Ingredients preliminary Q3 sales down 24%, cuts full-year guidance significantly
Preliminary Q3 sales $161.5M, -24% YoY; net income $23.9M (+82%) but adjusted EPS down 5% to $1.29.
Requires stockholders using Universal Proxy Rules to provide evidence of Rule 14a-19 compliance.
MGP Ingredients amends bylaws to address Universal Proxy Rules and update governance provisions
Board approved amended bylaws effective September 26, 2024.
MGP Ingredients Q2 2024: adjusted EPS up 15% to $1.71; reaffirms FY guidance
Sales fell 9% to $190.8M due to Atchison closure; ex-distillery, sales up 7%.
MGP Ingredients shareholders elect nine directors, approve new equity plan at 2024 annual meeting
All four common-stock director nominees elected with >18.2M votes each; broker non-votes of 1.29M.
MGP Ingredients Q1 net income down 34% to $20.6M; reaffirms FY2024 guidance
Sales decreased 15% to $170.6M; gross profit down 10% to $62.8M.
MGP Ingredients Chief Legal Officer Curtis Landherr resigns; transition period through May 31, 2024
Curtis Landherr, Chief Legal Officer, VP, and Corporate Secretary, resigns effective May 31, 2024; officer roles end April 30.
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
On April 14, 2025, Gerardo I. Lopez and Martin Roper were elected as Group B members of the Board of Directors (the “Board”) of MGP Ingredients, Inc.
In addition, Preet H. Michelson resigned as a Group B member of the Board, effective April 14, 2025.
On April 22, 2024, Curtis C. Landherr, the Chief Legal Officer, Vice President, and Corporate Secretary and a named executive officer of MGP Ingredients, Inc. (the “Company”) notified the Company that he is resigning from the Company, effective May 31, 2024.
Max materiality 0.85 · Median 0.60 · Most common event earnings